Physician profile
Loretta Ann Cacace
NPI 1598128761
$5,625.40
in general payments reported to CMS, 2019-2025
17 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $812 · 2020: $176 · 2021: $215 · 2022: $3,007 · 2023: $228 · 2024: $32.48 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $766 · Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $766.24 |
| Food and Beverage | $648.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,227.79 | 2022 | |
| Suvon Surgical LLC | $1,214.39 | 2022-2025 | |
| Integra Lifesciences Corporation | $926.74 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Treace Medical Concepts, INC. | $799.42 | 2025 | |
| Stryker Corporation | $390.53 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Paragon 28, INC. | $278.64 | 2021-2022 | |
| Derma Sciences, INC. | $209.93 | 2019 | |
| Smith+Nephew, INC. | $209.32 | 2021-2024 | Collagenase Santyl |
| Osteomed LLC | $110.42 | 2019-2021 | |
| Medtronic, INC. | $86.98 | 2025 | Hawkone |
| Royal Biologics, INC. | $72.10 | 2020 | |
| Solventum Corporation | $25.23 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Advanced Oxygen Therapy INC. | $21.53 | 2025 | Topical Oxygen Chamber For Extremities |
| Hydrofera LLC | $16.55 | 2022 | |
| Abbvie INC. | $15.61 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $11.22 | 2020 | |
| Kerecis Limited | $9.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loretta Cacace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.